3.9(top 10%)
impact factor
145(top 100%)
papers
2.8K(top 20%)
citations
27(top 20%)
h-index
4.0(top 10%)
extended IF
148
all documents
3.1K
doc citations
46(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Behçet’s disease physiopathology: a contemporary reviewAutoimmunity Highlights2016155
2Chemiluminescent immunoassay technology: what does it change in autoantibody detection?Autoimmunity Highlights2017154
3Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatmentAutoimmunity Highlights2017137
4International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA resultsAutoimmunity Highlights2016116
5Myositis autoantibodies and clinical phenotypesAutoimmunity Highlights201495
6Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment optionsAutoimmunity Highlights201984
7The Th17 axis in psoriatic disease: pathogenetic and therapeutic implicationsAutoimmunity Highlights201483
8Reactive oxygen species in organ-specific autoimmunityAutoimmunity Highlights201678
9Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunityAutoimmunity Highlights201263
10Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosisAutoimmunity Highlights201463
11Associations between HLA and autoimmune neurological diseases with autoantibodiesAutoimmunity Highlights202063
12Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based surveyAutoimmunity Highlights201655
13Transformation of fibroblast‐like synoviocytes in rheumatoid arthritis; from a friend to foeAutoimmunity Highlights202153
14Pathophysiology of the antiphospholipid antibody syndromeAutoimmunity Highlights201150
15The soluble CTLA-4 receptor and its role in autoimmune diseases: an updateAutoimmunity Highlights201048
16Natural killer cells in patients with severe chronic fatigue syndromeAutoimmunity Highlights201345
17Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severityAutoimmunity Highlights201944
18Blocking type TSH receptor antibodiesAutoimmunity Highlights201343
19Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effectiveAutoimmunity Highlights201641
20Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questionsAutoimmunity Highlights202039
21Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratoryAutoimmunity Highlights201237
22In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70)Autoimmunity Highlights201235
23Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravationAutoimmunity Highlights201835
24Decreased serum cell-free DNA levels in rheumatoid arthritisAutoimmunity Highlights201534
25Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferentAutoimmunity Highlights201232
26Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideAutoimmunity Highlights201432
27Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?Autoimmunity Highlights201832
28Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositisAutoimmunity Highlights201631
29Automation, consolidation, and integration in autoimmune diagnosticsAutoimmunity Highlights201530
30Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patientsAutoimmunity Highlights201530
31Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case–control and population case–control designAutoimmunity Highlights202029
32NF-κB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytesAutoimmunity Highlights202029
33Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platformsAutoimmunity Highlights201728
34Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximabAutoimmunity Highlights201027
35Autoimmunity in connection with a metal implant: a case of autoimmune/autoinflammatory syndrome induced by adjuvantsAutoimmunity Highlights201327
36Deciphering the role of DNA methylation in multiple sclerosis: emerging issuesAutoimmunity Highlights201626
37Infections as a cause of autoimmune rheumatic diseasesAutoimmunity Highlights201626
38Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrateAutoimmunity Highlights201726
39Missing links in high quality diagnostics of inflammatory systemic rheumatic diseasesAutoimmunity Highlights201225
40The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observationAutoimmunity Highlights201425
41Personalized medicine in rheumatology: the paradigm of serum autoantibodiesAutoimmunity Highlights201725
42The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnosticsAutoimmunity Highlights201624
43Effect of janus kinase inhibitors and methotrexate combination on malignancy in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trialsAutoimmunity Highlights202122
44Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosisAutoimmunity Highlights201321
45Intraepithelial lymphocytes subsets in different forms of celiac diseaseAutoimmunity Highlights201621
46A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3)Autoimmunity Highlights201420
47Structure and activation of the TSH receptor transmembrane domainAutoimmunity Highlights201720
48Protective effect of TSLP and IL-33 cytokines in ulcerative colitisAutoimmunity Highlights201920
49The perspective on standardisation and harmonisation: the viewpoint of the EASI presidentAutoimmunity Highlights202020
50Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA — evidence-based immunology?Autoimmunity Highlights201019